Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis. - Wikidata - wikimedia - TriplyDB

Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis.

Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis.

http://www.wikidata.org/entity/Q35085227

about

Immunological aspects of endometriosis: a review Inhibition of CD36-dependent phagocytosis by prostaglandin E2 contributes to the development of endometriosis Indoleamine 2,3-dioxygenase-1 (IDO1) in human endometrial stromal cells induces macrophage tolerance through interleukin-33 in the progression of endometriosis Lack of EP4 receptors on bone marrow-derived cells enhances inflammation in atherosclerotic lesions.Targeting CD13 (aminopeptidase-N) in turn downregulates ADAM17 by internalization in acute myeloid leukaemia cells.Deletion of EP4 on bone marrow-derived cells enhances inflammation and angiotensin II-induced abdominal aortic aneurysm formation.Cyclic adenosine 3',5'-monophosphate response element-binding protein and CCAAT/enhancer-binding protein mediate prostaglandin E2-induced steroidogenic acute regulatory protein expression in endometriotic stromal cells.Comparison of RCAS1 and metallothionein expression and the presence and activity of immune cells in human ovarian and abdominal wall endometriomas Lipoxin A₄ prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E₂ production and estrogen signaling Immune interactions in endometriosis.Effect of the non-specific matrix metalloproteinase inhibitor Doxycycline on endometriotic implants in an experimental rat model.Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases.CD4+Foxp3+ regulatory T cell differentiation mediated by endometrial stromal cell-derived TECK promotes the growth and invasion of endometriotic lesions.PGE2-induced metalloproteinase-9 is essential for dendritic cell migration.Endometriosis, a disease of the macrophage Recklessness as a hallmark of aggressive cancer.Medical management of endometriosis: emerging evidence linking inflammation to disease pathophysiology Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease Co-micronized Palmitoylethanolamide/Polydatin Treatment Causes Endometriotic Lesion Regression in a Rodent Model of Surgically Induced Endometriosis.Different effects of the immunomodulatory drug GMDP immobilized onto aminopropyl modified and unmodified mesoporous silica nanoparticles upon peritoneal macrophages of women with endometriosis.The M2 polarization of macrophage induced by fractalkine in the endometriotic milieu enhances invasiveness of endometrial stromal cells Prostaglandin E2: the master of endometriosis?Serum soluble CD163 and interleukin-6 levels in women with ovarian endometriomas.Pathogenetic Mechanisms of Deep Infiltrating Endometriosis.MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis?Somatostatin analogs regress endometriotic implants in rats by decreasing implant levels of vascular endothelial growth factor and matrix metaloproteinase 9.Hypoxia-inhibited dual-specificity phosphatase-2 expression in endometriotic cells regulates cyclooxygenase-2 expression.Experimental endometriosis in the rat is correlated with colonic motor function alterations but not with bacterial load.Targeting hypoxia-mediated YAP1 nuclear translocation ameliorates pathogenesis of endometriosis without compromising maternal fertility.Downregulation of CD36 results in reduced phagocytic ability of peritoneal macrophages of women with endometriosis.Performance of peripheral (serum and molecular) blood markers for diagnosis of endometriosis

P2860

Q26798439-5CC9BA58-2FA4-4299-99BE-53876C33A8E1 Q33597181-11B3CA3D-0E1E-4277-A560-170078DD004E Q33898659-8FA87446-3F26-45D5-B8D3-910E421039A4 Q34410269-F879F2F7-583B-4522-846E-8320A13BAD54 Q34483504-53C80D54-7569-4773-B189-B8F0112547D6 Q34514569-AD3093BC-D3ED-4B82-A696-D98972DE28F4 Q34656603-AF2A5915-1F14-4EE3-8F56-D6AA760F49C7 Q35046439-C0817600-B6BA-4E31-B802-7795F317E33E Q35107985-FA3E1A2E-9421-47A3-A1D0-C334A62A8CFA Q35486220-895F032B-B1E7-4EE1-A74C-0A57007449DF Q35754183-8D9D38EA-94A6-41C2-ABA0-7DE86BD43F66 Q35825211-3CC6D9F7-45C9-4C23-9EAD-61A8B5A16C86 Q36291143-643F0E85-0F75-4A60-9A0D-9F9FD4301D1C Q36384618-D6D6599C-5E2C-4B6B-9B31-9CE7DB433528 Q36566594-A0326129-C376-4273-BF8D-92DE5DF15B33 Q36921698-E2FEA768-C319-4F57-897D-EB517BA70F0E Q37032251-AF60CC13-976A-4F21-8A72-8582277328E5 Q37278432-4106BE4F-1740-4DAB-B6CE-17987176D9E9 Q37338638-AD5F3A1B-BDB5-4F83-80BE-BEA2CD4D4FCF Q37448466-9A6701AF-ABEB-4AA1-AF9D-04E92E60C609 Q37452210-36284476-043C-4792-BFFB-A6EAC14B18EB Q37761617-55F0F400-6A97-4B8D-AC06-0A5D09C871D1 Q38502018-15F35D2E-D82B-44D9-9C7A-2DAB5A6558B3 Q38546195-65CBC19D-F520-4D46-A1D8-BC5E30B0886B Q38590189-6A14C150-3E1C-40D7-8E36-439C71AAE7F6 Q45037533-379C57B8-BE7B-4BA1-8A94-EAEF83FF4ADE Q45910538-A26BE256-DEA2-4BC1-834A-F85BA683D015 Q46843643-49B9A199-0C13-4235-BCE6-3E5771C94548 Q47864626-42225182-B2D1-4850-AB26-B086DC863E62 Q54473211-986215F1-B948-4C83-9F4E-D8995DECC40E Q56981657-74AE6EC9-EAF7-4B7E-9EC8-08F4DA440521

P2860

Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis.

http://www.wikidata.org/entity/Q35085227

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Suppression of matrix metallop ...... ith severity of endometriosis.

@ast

Suppression of matrix metallop ...... ith severity of endometriosis.

@en

type

label

Suppression of matrix metallop ...... ith severity of endometriosis.

@ast

Suppression of matrix metallop ...... ith severity of endometriosis.

@en

prefLabel

Suppression of matrix metallop ...... ith severity of endometriosis.

@ast

Suppression of matrix metallop ...... ith severity of endometriosis.

@en

P1433

Q35085227-C979556B-51EC-481F-848F-B48A6242E499

P1476

Q35085227-F3E8C713-0A64-49D9-AB41-53002FA82F59

P2093

Q35085227-2FF54265-C1D7-49BA-8F14-8A9D548E5AA3

Q35085227-465C0C64-947C-40E3-8F7D-DCFD66882140

Q35085227-6495AB67-09B8-4B78-B7C3-EEB4192B9357

Q35085227-70B5E8B0-7DED-4A99-B80D-BE825F7B75A8

Q35085227-760E3E42-07E8-4ED5-90AF-1F6001D75A61

Q35085227-B568F86B-0CD8-4A93-8BA5-C284F195AE5F

Q35085227-ED317684-8AC4-4EDC-A497-6FDE231CC8E6

P2860

Q35085227-05970E53-E488-4D99-8B81-6A5C05818C23

Q35085227-0AB387F3-A136-4F30-B9D8-9E0AE4391770

Q35085227-0D2C69B7-598D-4615-B1EE-B4620C291553

Q35085227-13073F20-0704-4EDD-8D13-54152A290F82

Q35085227-1513F420-6778-4A8A-9ED7-E4DF1159C658

Q35085227-1AC7C149-9F00-4120-88DA-E80059806E82

Q35085227-1D6FA39C-084A-44C4-80DA-8E8C4154839B

Q35085227-273C0D95-06B6-43F0-8C36-033E5C5044EF

Q35085227-3FB82FC5-C750-4E44-BDDF-F9F0B5CF2B2A

Q35085227-50A3419E-29CF-44D3-8091-FE0F6FBA2484

P304

Q35085227-7483B8B7-8D9A-4B84-BED3-130B538435BE

P31

Q35085227-AA26AABB-5AA9-40A3-8C5F-930D97B16E4A

P356

Q35085227-80874375-6CEC-490D-BC78-5AA755CC2CAC

P407

Q35085227-8FC02B40-5C9F-40CC-9938-C5334E264E3A

P433

Q35085227-C51A8FE4-0082-4440-B5CE-9860E99B0D47

P478

Q35085227-102249CC-AA35-4685-8D2E-16B40DE7041D

P577

Q35085227-527FD0E5-3624-49B1-838D-EA3D98189199

P5875

Q35085227-4B30BB80-5297-49AC-BF04-FB75998DA846

P698

Q35085227-C7CF083F-6072-4AC6-BD7C-E25ACB7439E0

P921

Q35085227-0F52A69F-4BA9-49A3-9769-E808BEA1F089

Q35085227-27E9D738-F6EE-407B-8E73-5032EADBD6FD

P932

Q35085227-E215344B-DFA1-4A83-BDDB-C7D40B182295

P356

S0002-9440(10)61195-9

P1433

The American Journal of Pathology

P1476

Suppression of matrix metallop ...... ith severity of endometriosis.

@en

P2093

Chen-Chung Lin

http://www.w3.org/2001/XMLSchema#string

Mei-Feng Huang

http://www.w3.org/2001/XMLSchema#string

Meng-Chi Wu

http://www.w3.org/2001/XMLSchema#string

Meng-Hsing Wu

http://www.w3.org/2001/XMLSchema#string

Pei-Chin Chuang

http://www.w3.org/2001/XMLSchema#string

Shaw-Jenq Tsai

http://www.w3.org/2001/XMLSchema#string

Yutaka Shoji

http://www.w3.org/2001/XMLSchema#string

P2860

Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms

Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms

Gelatinase B functions as regulator and effector in leukocyte biology

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

Prostanoid receptors: subtypes and signaling.

Transactivation of steroidogenic acute regulatory protein in human endometriotic stromalcells is mediated by the prostaglandin EP2 receptor.

Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development.

Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

Estrogen production and metabolism in endometriosis.

RECKing MMP function: implications for cancer development.

P304

1061-1069

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)61195-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

167

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7571589

http://www.w3.org/2001/XMLSchema#string

P698

16192641

http://www.w3.org/2001/XMLSchema#string

P921

P932

1603672

http://www.w3.org/2001/XMLSchema#string